WallStreetZenWallStreetZen

NASDAQ: NPCE
Neuropace Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Neuropace earnings were -$21.6M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest NPCE earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$6.7M, up 145.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, NPCE reported annual earnings of -$21.5M, with -20.9% growth. The next NPCE earnings date is Aug 11, 2026.

NPCE earnings history

Current Revenue
$99.5M
Current Earnings
-$21.6M
Current Profit Margin
-21.7%

NPCE Return on Equity

Current Company
-120.7%
Current Industry
6.5%
Current Market
13.5%
NPCE's Return on Equity (-120.7%)... subscribe to Premium to read more.
High Return on Equity Performance

NPCE Return on Assets

Current Company
-20.6%
Current Industry
5.8%
NPCE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NPCE announces earnings.

NPCE Return on Capital Employed

Current Company
-17.82%
Current Industry
9.4%
NPCE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NPCE vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NPCE-$12.74M-$21.57MN/A-$0.65
CLPT-$22.24M-$29.07MN/A-$1.00
CERS$3.07M-$9.55MN/A-$0.05
CTKB-$24.55M-$74.00MN/A-$0.57
KIDS-$10.82M-$39.68MN/A-$1.68
View Top Medical Device Stocks

NPCE earnings dates

Next earnings date
Aug 11, 2026

Neuropace Earnings Reports & History FAQ

What were Neuropace's earnings last quarter?

Neuropace (NASDAQ: NPCE) reported Q1 2026 earnings per share (EPS) of -$0.20, up 4.76% year over year. Total NPCE earnings for the quarter were -$6.69 million. In the same quarter last year, Neuropace's earnings per share (EPS) was -$0.21.

If you're new to stock investing, here's how to buy Neuropace stock.

When does Neuropace report earnings?

The next NPCE earnings date is Invalid Date. Add NPCE to your watchlist to be reminded of Neuropace's next earnings date.

Is Neuropace profitable or losing money?

As of the last Neuropace earnings report, Neuropace is currently losing money. Neuropace's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$21.57 million, a 13.06% decrease year over year.

What was NPCE's earnings growth in the past year?

As of Neuropace's earnings date in Q2 2026, Neuropace's earnings has grown year over year. NPCE earnings in the past year totalled -$21.57 million.

What are Neuropace's earnings expectations?

The current EPS estimate for Neuropace's earnings report in Invalid Date is -$0.20.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.